Association between depression subtypes and response to repeated-dose intravenous ketamine.
C WangY ZhouWei ZhengW LiuY ZhanH LiL ChenB ZhangM WalterM LiM D LiYu-Ping NingPublished in: Acta psychiatrica Scandinavica (2019)
Our study shows promising results for ketamine as a novel antidepressant preferentially for the treatment of non-melancholic or anxious depression.